Dehydroepiandrosterone (DHEA): Pharmacological Effects and Potential Therapeutic Application
- PMID: 36121077
- DOI: 10.2174/1389557522666220919125817
Dehydroepiandrosterone (DHEA): Pharmacological Effects and Potential Therapeutic Application
Abstract
Dehydroepiandrosterone (DHEA) is the most abundant steroid hormone in primates, which is predominantly synthesized in the adrenal cortex. A characteristic curve of growth and decline of its synthesis during life was observed, together with the corresponding formation of its sulphate ester (DHEAS). High levels of plasma circulating DHEA are suggested as a marker of human longevity, and various pathophysiological conditions lead to a decreased DHEA level, including adrenal insufficiency, severe systemic diseases, acute stress, and anorexia. More recent studies have established the importance of DHEA in the central nervous system (CNS). A specific intranuclear receptor for DHEA has not yet been identified; however, highly specific membrane receptors have been detected in endothelial cells, the heart, kidney, liver, and the brain. Research shows that DHEA and DHEAS, as well as their metabolites, have a wide range of effects on numerous organs and organ systems, which places them in the group of potential pharmacological agents useful in various clinical entities. Their action as neurosteroids is especially interesting due to potential neuroprotective, pro-cognitive, anxiolytic, and antidepressant effects. Evidence from clinical studies supports the use of DHEA in hypoadrenal individuals and in treating depression and associated cognitive disorders. However, there is also an increasing trend of recreational DHEA misuse in healthy people, as it is classified as a dietary supplement in some countries. This article aims to provide a critical review regarding the biological and pharmacological effects of DHEA, its mechanism of action, and potential therapeutic use, especially in CNS disorders.
Keywords: Dehydroepiandrosterone; biosynthesis; neurosteroid; pharmacology; supplementation; therapy.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).Front Neuroendocrinol. 2009 Jan;30(1):65-91. doi: 10.1016/j.yfrne.2008.11.002. Epub 2008 Dec 3. Front Neuroendocrinol. 2009. PMID: 19063914 Free PMC article. Review.
-
Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.Drugs Aging. 2003;20(13):949-67. doi: 10.2165/00002512-200320130-00001. Drugs Aging. 2003. PMID: 14561100 Review.
-
[New therapeutic avenues for neurosteroids in psychiatric diseases].Biol Aujourdhui. 2019;213(3-4):131-140. doi: 10.1051/jbio/2019023. Epub 2019 Dec 12. Biol Aujourdhui. 2019. PMID: 31829933 Review. French.
-
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.Gynecol Endocrinol. 2000 Oct;14(5):342-63. doi: 10.3109/09513590009167703. Gynecol Endocrinol. 2000. PMID: 11109974 Clinical Trial.
-
Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases.Int Rev Neurobiol. 2001;46:379-97. doi: 10.1016/s0074-7742(01)46069-7. Int Rev Neurobiol. 2001. PMID: 11599307 Review.
Cited by
-
Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders.Life (Basel). 2024 Apr 30;14(5):582. doi: 10.3390/life14050582. Life (Basel). 2024. PMID: 38792602 Free PMC article. Review.
-
The role of environmental sensitivity in the mental health of Syrian refugee children: a multi-level analysis.Mol Psychiatry. 2024 May 3. doi: 10.1038/s41380-024-02573-x. Online ahead of print. Mol Psychiatry. 2024. PMID: 38702371
-
Effect of Probiotic Therapy on Neuropsychiatric Manifestations in Children with Multiple Neurotransmitter Disorders: A Study.Biomedicines. 2023 Sep 26;11(10):2643. doi: 10.3390/biomedicines11102643. Biomedicines. 2023. PMID: 37893017 Free PMC article.
-
The Hypothalamic-Pituitary-Gonadal Axis in Men with Schizophrenia.Int J Mol Sci. 2023 Mar 30;24(7):6492. doi: 10.3390/ijms24076492. Int J Mol Sci. 2023. PMID: 37047464 Free PMC article. Review.
-
Acquired Glucose-6-Phosphate Dehydrogenase Deficiency.J Clin Med. 2022 Nov 11;11(22):6689. doi: 10.3390/jcm11226689. J Clin Med. 2022. PMID: 36431166 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources